Junjie Kou

1.4k total citations
44 papers, 1.1k citations indexed

About

Junjie Kou is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Junjie Kou has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 21 papers in Immunology and 16 papers in Hematology. Recurrent topics in Junjie Kou's work include Phagocytosis and Immune Regulation (12 papers), Platelet Disorders and Treatments (10 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers). Junjie Kou is often cited by papers focused on Phagocytosis and Immune Regulation (12 papers), Platelet Disorders and Treatments (10 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (8 papers). Junjie Kou collaborates with scholars based in China, United States and Canada. Junjie Kou's co-authors include Yayan Bi, Jialan Shi, Zengxiang Dong, Ruishuang Ma, Valerie A. Novakovic, Muhua Cao, Yan Kou, Daxun Piao, Zhipeng Yao and Zhangxiu He and has published in prestigious journals such as Blood, PLoS ONE and Analytical Chemistry.

In The Last Decade

Junjie Kou

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junjie Kou China 21 587 325 199 127 122 44 1.1k
Angelique L. Rops Netherlands 26 664 1.1× 302 0.9× 317 1.6× 109 0.9× 120 1.0× 43 2.0k
Chandra C. Ghosh United States 18 557 0.9× 292 0.9× 111 0.6× 182 1.4× 167 1.4× 47 1.3k
Martin F. Brodde Germany 16 382 0.7× 188 0.6× 243 1.2× 76 0.6× 112 0.9× 23 984
Michael Tencati United States 14 377 0.6× 478 1.5× 517 2.6× 133 1.0× 111 0.9× 17 1.5k
Randolph Hutter United States 18 374 0.6× 320 1.0× 94 0.5× 144 1.1× 141 1.2× 31 1.2k
Takatoshi Koyama Japan 28 504 0.9× 347 1.1× 601 3.0× 145 1.1× 105 0.9× 92 2.0k
Bhanu Kanth Manne United States 21 529 0.9× 400 1.2× 551 2.8× 153 1.2× 163 1.3× 44 1.8k
Binggang Xiang United States 11 360 0.6× 243 0.7× 298 1.5× 42 0.3× 75 0.6× 14 843
J Ryan United States 18 636 1.1× 341 1.0× 348 1.7× 142 1.1× 149 1.2× 23 1.8k
James H. Finigan United States 17 307 0.5× 149 0.5× 189 0.9× 79 0.6× 333 2.7× 25 974

Countries citing papers authored by Junjie Kou

Since Specialization
Citations

This map shows the geographic impact of Junjie Kou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junjie Kou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junjie Kou more than expected).

Fields of papers citing papers by Junjie Kou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junjie Kou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junjie Kou. The network helps show where Junjie Kou may publish in the future.

Co-authorship network of co-authors of Junjie Kou

This figure shows the co-authorship network connecting the top 25 collaborators of Junjie Kou. A scholar is included among the top collaborators of Junjie Kou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junjie Kou. Junjie Kou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tong, Xiao, et al.. (2023). circRNA, a novel diagnostic biomarker for coronary heart disease. Frontiers in Cardiovascular Medicine. 10. 1070616–1070616. 6 indexed citations
3.
Tong, Xiao, et al.. (2023). Biomarkers Associated with Immune Checkpoint, N6-Methyladenosine, and Ferroptosis in Patients with Restenosis. Journal of Inflammation Research. Volume 16. 407–420. 2 indexed citations
4.
Tong, Xiao, Dongmei Liu, Ning Wang, et al.. (2023). Exosome-derived circ_0001785 delays atherogenesis through the ceRNA network mechanism of miR-513a-5p/TGFBR3. Journal of Nanobiotechnology. 21(1). 362–362. 26 indexed citations
5.
Tong, Xiao, et al.. (2022). Predicting Diagnostic Gene Biomarkers Associated With Immune Checkpoints, N6-Methyladenosine, and Ferroptosis in Patients With Acute Myocardial Infarction. Frontiers in Cardiovascular Medicine. 9. 836067–836067. 14 indexed citations
6.
Wang, Fan, Jian Xu, Shaojun Li, et al.. (2021). Berberine improves dietary-induced cardiac remodeling by upregulating Kruppel-like factor 4-dependent mitochondrial function. Biological Chemistry. 402(7). 795–803. 12 indexed citations
7.
Kou, Yan, Lili Zou, Ruipeng Liu, et al.. (2019). Intravascular cells and circulating microparticles induce procoagulant activity via phosphatidylserine exposure in heart failure. Journal of Thrombosis and Thrombolysis. 48(2). 187–194. 18 indexed citations
8.
Su, Ying, Jingli Chen, Zengxiang Dong, et al.. (2018). Procoagulant Activity of Blood and Endothelial Cells via Phosphatidylserine Exposure and Microparticle Delivery in Patients with Diabetic Retinopathy. Cellular Physiology and Biochemistry. 45(6). 2411–2420. 17 indexed citations
9.
Li, Tao, Ruishuang Ma, Xiaoyan Yang, et al.. (2018). Arsenic trioxide promoting ETosis in acute promyelocytic leukemia through mTOR-regulated autophagy. Cell Death and Disease. 9(2). 75–75. 41 indexed citations
10.
Wang, Lixiu, Yayan Bi, Muxin Yu, et al.. (2018). Phosphatidylserine-exposing blood cells and microparticles induce procoagulant activity in non-valvular atrial fibrillation. International Journal of Cardiology. 258. 138–143. 34 indexed citations
11.
Ma, Ruishuang, Rui Xie, Chengyuan Yu, et al.. (2017). Phosphatidylserine-mediated platelet clearance by endothelium decreases platelet aggregates and procoagulant activity in sepsis. Scientific Reports. 7(1). 4978–4978. 42 indexed citations
12.
Liu, Huidi, Emilio Mastriani, Siyuan Yin, et al.. (2016). SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer. Scientific Reports. 6(1). 26136–26136. 29 indexed citations
13.
Ma, Ruishuang, Mingming Cao, Yu Si, et al.. (2016). Extracellular DNA traps released by acute promyelocytic leukemia cells through autophagy. Cell Death and Disease. 7(6). e2283–e2283. 41 indexed citations
14.
Zhao, Liangliang, Yayan Bi, Junjie Kou, Jialan Shi, & Daxun Piao. (2016). Phosphatidylserine exposing-platelets and microparticles promote procoagulant activity in colon cancer patients. Journal of Experimental & Clinical Cancer Research. 35(1). 54–54. 71 indexed citations
15.
Gao, Chunyan, Rui Xie, Chengyuan Yu, et al.. (2015). Thrombotic Role of Blood and Endothelial Cells in Uremia through Phosphatidylserine Exposure and Microparticle Release. PLoS ONE. 10(11). e0142835–e0142835. 40 indexed citations
16.
Ma, Ruishuang, Yan Zhang, Muhua Cao, et al.. (2015). Phosphotidylserine exposure and neutrophil extracellular traps enhance procoagulant activity in patients with inflammatory bowel disease. Thrombosis and Haemostasis. 115(4). 738–751. 83 indexed citations
18.
He, Zhangxiu, Muhua Cao, Ruishuang Ma, et al.. (2015). Increased phosphatidylserine-exposing microparticles and their originating cells are associated with the coagulation process in patients with IgA nephropathy. Nephrology Dialysis Transplantation. 31(5). 747–759. 18 indexed citations
19.
Zhang, Yan, Huan Meng, Ruishuang Ma, et al.. (2015). Circulating Microparticles, Blood Cells, and Endothelium Induce Procoagulant Activity in Sepsis Through Phosphatidylserine Exposure. Shock. 45(3). 299–307. 74 indexed citations
20.
Jing, Ling, Weimin Li, Lijun Zhou, et al.. (2008). Expression of Renin‐Angiotensin System and Peroxisome Proliferator‐Activated Receptors in Alcoholic Cardiomyopathy. Alcoholism Clinical and Experimental Research. 32(11). 1999–2007. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026